– Data to be released at approximately 6:00 p.m. ET, following presentation at 2023 SABCS –– Conference call to commence at 6:30 p.m. ET –SAN JOSE, Calif., Dec. 6, 2023 /PRNewswire/ -- Anixa Biosciences,
Fiscal Year 2023 The company raises full-year outlook to reflect third quarter performance: • Consolidated net sales growth of about 5.5%. Excluding divestitures3 , consolidated net sales growth of about 6.5%. Based